GE inks $21 billion biopharma sale to Danaher in U-turn under Culp

General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate’s chief executive in September.

…read more

Source:: Reuters – Business News